FIELD: medicine; sleep pathophysiology.
SUBSTANCE: following is provided: the methods of treating a circadian rhythm sleep disorder and improving one or more sleep parameters in a patient having a genotype selected from the group consisting of the CRY1 genotype with the rs184039278 allele, the CRY1 genotype with the rs780614131 allele, and the PER1 genotype with the rs112474322 allele. The methods include administering of an effective amount of tasimelteon to the said patient.
EFFECT: group of inventions provides effective treatment of a circadian sleep rhythm disorder or one or more symptoms associated with this disorder and improvement of one or more sleep parameters in an individual who has a circadian clock 1 (CRY1) cryptochrome genotype or a period 1 (PER1) genotype by introducing of tasimelteon to the said individual.
12 cl, 2 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF IMPROVING SLEEP AND PERFORMANCE AFTER SLEEP | 2019 |
|
RU2822076C2 |
IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2812890C2 |
TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2013 |
|
RU2748386C2 |
LIQUID COMPOSITIONS CONTAINING TASIMELTEON AND METHODS OF THEIR USE | 2020 |
|
RU2806302C1 |
IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2793237C2 |
TREATING ATOPIC DERMATITIS WITH TRADIPITANT | 2021 |
|
RU2818164C1 |
METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
TREATMENT OF CIRCADIAN RHYTHM VIOLATIONS | 2013 |
|
RU2631602C2 |
TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2013 |
|
RU2650647C2 |
USE OF TRADIPITANT FOR MOTION SICKNESS | 2019 |
|
RU2808669C2 |
Authors
Dates
2023-09-29—Published
2020-02-13—Filed